Condition: Psoriasis · Sponsor: Janssen Research & Development, LLC
This study aims to assess the proportion of participants with moderate-to-severe plaque psoriasis who continue treatment with guselkumab over a two-year period.
This description comes directly from the study's public registry record.
Study Contact · 844-434-4210 · Participate-In-This-Study1@its.jnj.com
Always discuss trial participation with your own doctor first.
| Mihaila G. Georgiana - Cabinet Medical Individual Dermatovenerologie | Bârlad, Romania | Recruiting |
| Qualimed SRL | Brasov, Romania | Recruiting |
| Spitalul Universitar de Urgenta Elias, Clinica de Cardiologie | Bucharest, Romania | Recruiting |
| Spitalul Clinic Colentina 1 | Bucharest, Romania | Recruiting |
| Spitalul Clinic Colentina | Bucharest, Romania | Recruiting |
| Alin Nicolescu Medic Primar Dermato Venerologie | Bucharest, Romania | Recruiting |
| OptiDerm Estet | Bucharest, Romania | Recruiting |
| Spitalul Clinic Judetean de Urgenta Cluj Napoca | Cluj-Napoca, Romania | Recruiting |
| Ambulator Specialitate Sp Militar de Urgenta Dr Constantin Papilian Cluj Napoca | Cluj-Napoca, Romania | Recruiting |
| Innovative Derm SRL | Constanța, Romania | Recruiting |
| Policlinica Dr.Corbeanu | Craiova, Romania | Recruiting |
| Policlinica Top Med Buna Vestire | Craiova, Romania | Recruiting |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07582783